Titan Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Titan Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $2.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Titan Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $2.5M Trade | TransData Nexus

Titan Laboratories Private Limited

Indian Pharmaceutical Exporter · Antiviral & HIV Medications Specialist · $2.5M Total Trade · DGFT Verified

Titan Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.5M across 6 products in 5 therapeutic categories. Based on 77 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Raltegravir ($1.1M), Exemestane ($500.0K), Nitrofurantoin ($476.6K).

Titan Laboratories Private Limited — Export Portfolio & Destination Treemap

Titan Laboratories Private Limited pharmaceutical export portfolio — 6 products across 5 therapeutic categories. Source: Indian Customs (DGFT).

Who is Titan Laboratories Private Limited? — Company Overview & Market Position

Titan Laboratories Private Limited, incorporated on June 14, 2004, is a private pharmaceutical company based in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24100MH2004PTC146928. Its authorized capital is ₹200 lakhs, with a paid-up capital of ₹196.81 lakhs, reflecting a paid-up capital percentage of 98.405%. The registered office is located at A/01-GF & A/101, Plot No. 120, Anand Bhavan, Spectrum Building, R B Mehta Marg, Tilak Road, Ghatkopar East, Mumbai City, Maharashtra 400077, India. The company specializes in the manufacturing of pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to various therapeutic categories.

What Does Titan Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Raltegravir$1.1M 2Exemestane$500.0K

Product Portfolio — Top 6 by Export Value

Titan Laboratories Private Limited exports 6 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Raltegravir	Antiviral & HIV Medications	$1.1M	21	16.3%	2
2	Exemestane	Advanced Oncology	$500.0K	10	3.5%	6
3	Nitrofurantoin	Advanced Antibiotics	$476.6K	15	1.4%	12
4	Melatonin	Nutritional Supplements	$262.1K	25	2.8%	11
5	Minocycline	Advanced Antibiotics	$150.0K	3	0.7%	10
6	Leflunomide	Immunosuppressants	$105.6K	3	0.7%	14

Titan Laboratories Private Limited exports 6 pharmaceutical products across 5 therapeutic categories with a total export value of $2.5M. The top category is Antiviral & HIV Medications (41.3% of portfolio), followed by Advanced Antibiotics (24.6%), indicating a concentrated portfolio with the top 5 products accounting for 95.8% of total export value.

Titan Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Titan Laboratories Private Limited operates manufacturing facilities in Mumbai, Maharashtra. While specific details regarding plant capacities and specializations are not publicly disclosed, the company's product portfolio indicates a focus on finished pharmaceutical formulations. The manufacturing processes adhere to industry standards to ensure the production of high-quality pharmaceutical products.

3Key Leadership

The company's leadership comprises directors Piyush Bhailal Shah and Deepak Bhailal Shah. Specific roles and responsibilities of these directors are not publicly detailed. The company's governance structure is designed to oversee operations and strategic direction effectively.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Titan Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Titan Laboratories Private Limited's export data indicates a presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has engaged in 77 shipments across six products in five therapeutic categories, with a total export value of $2.5 million USD. Notably, the top five products include Raltegravir, Exemestane, Nitrofurantoin, Melatonin, and Minocycline, collectively accounting for 95.8% of the export value. However, specific regulatory approvals or market access statuses in these regions are not publicly disclosed.

2Emerging Markets

Titan Laboratories Private Limited's export data does not provide specific information regarding its penetration into emerging markets such as Africa, Latin America, and Southeast Asia. The company's export activities are primarily focused on regulated markets, with no explicit mention of WHO prequalification or similar certifications that would facilitate access to these emerging markets.

3Geographic Strategy

The company's export activities are concentrated in regulated markets, with a significant focus on the United States, European Union, United Kingdom, Australia, and Japan. This concentration suggests a strategic emphasis on markets with established regulatory frameworks and demand for pharmaceutical products. While this approach may reduce exposure to emerging market risks, it also indicates a potential opportunity for geographic diversification to mitigate market-specific challenges.

Titan Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Titan Laboratories Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data does not provide insights into its standing with the U.S. Food and Drug Administration (FDA). This lack of publicly accessible information makes it challenging to assess the company's compliance and standing within the U.S. regulatory framework.

2WHO & EU GMP

There is no publicly available information regarding Titan Laboratories Private Limited's World Health Organization (WHO) prequalification status or European Union Good Manufacturing Practice (EU GMP) certifications. The company's export data does not indicate any certifications that would facilitate access to international markets requiring such standards. This absence suggests that the company may not currently hold these certifications, which are often essential for global market access.

3CDSCO & Indian Regulatory

Titan Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Titan Laboratories Private Limited operates in a competitive pharmaceutical industry, exporting products across various therapeutic categories. While specific competitors in overlapping categories are not identified, the company's export data indicates a focus on products such as Raltegravir, Exemestane, Nitrofurantoin, Melatonin, and Minocycline. The market shares of these products range from 0.7% to 16.3%, suggesting a presence in competitive segments. A detailed market share comparison and head-to-head analysis would require access to comprehensive industry data and competitor performance metrics.

2Key Differentiators

Titan Laboratories Private Limited's key differentiators include its specialization in finished pharmaceutical formulations across multiple therapeutic categories, with a significant concentration in Antiviral & HIV Medications, Advanced Antibiotics, and Advanced Oncology. The company's export data highlights a strong portfolio concentration, with the top five products accounting for 95.8% of the export value. This focus allows the company to leverage expertise in specific therapeutic areas, potentially enhancing product quality and market positioning.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Titan Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Titan Laboratories Private Limited demonstrates a consistent export volume, with 77 shipments across six products in five therapeutic categories, totaling $2.5 million USD. The top five products account for 95.8% of the export value, indicating a focused product strategy. While specific reliability indicators are not publicly disclosed, the company's sustained export activities suggest a stable and reliable supply chain.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the company's products are approved by the U.S. Food and Drug Administration (FDA). Verification can be done through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: Ensure that the manufacturing facilities comply with World Health Organization Good Manufacturing Practice standards. This can be verified by checking the WHO's official prequalification list or by requesting certification details from the company.

Frequently Asked Questions — Titan Laboratories Private Limited

How many pharmaceutical products does Titan Laboratories Private Limited export from India?

Titan Laboratories Private Limited exports 6 pharmaceutical products across 5 therapeutic categories. The top exports are Raltegravir ($1.1M), Exemestane ($500.0K), Nitrofurantoin ($476.6K), Melatonin ($262.1K), Minocycline ($150.0K). Total export value is $2.5M.

What is Titan Laboratories Private Limited's total pharmaceutical export value?

Titan Laboratories Private Limited's total pharmaceutical export value is $2.5M, based on 77 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Titan Laboratories Private Limited cover?

Titan Laboratories Private Limited exports across 5 therapeutic categories. The largest are Antiviral & HIV Medications (41.3%, 1 products), Advanced Antibiotics (24.6%, 2 products), Advanced Oncology (19.7%, 1 products).

Get Full Titan Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.